LeadR Profile

Alexander M M Eggermont Institut Gustave Roussy France
3 247 ScienceLeadR Reputation 3247
Network Map

Oncology

Subspecialties: Surgery - Immunology - Hematology

Full career Last 3 years

Main Topics

Publications and Clinical Studies

Publications Clinical Studies

Short Biography

Prof. Alexander Maximiliaan Marie EGGERMONT, MD, PhD

- Board of the Comprehensive Cancer Center Munich (CCCM), Technical University Munich & Ludwig Maximilians University, Munich, Germany

- Prof Clinical &Translational Immunotherapy, University Medical Center Utrecht, Netherlands - Senior Investigator and past Chief Scientific Officer Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands

- Coordinator Comprehensive Cancer Center Program Deutsche KrebsHilfe, Germany & Strategic Advisor @ DKFZ-NCT Heidelberg for National Center for Tumors Program, Germany

Past Director General, Gustave Roussy Cancer Campus Grand Paris, France (2010-2019) & Emeritus Professor Oncology, University Paris-Saclay, France (2012-2021)

Emeritus Professor International Networking Cancer Research, ErasmusMC, Rotterdam, NL Emeritus Professor Surgical Oncology Erasmus University Rotterdam, NLHonorary Professor Surgical Oncology, Catholic University Leuven, Belgium,

Fellow of USA NIH-NCI Surgery Branch (Steve Rosenberg) (85-86) PhD1987 TumorImmunology

International (current & past) scientific societal positions

  1. President European Academy of Cancer Sciences (2010-2019), Executive board (2019-now)
  2. President Cancer Core Europe 2014-2019
  3. ECCO President European CanCer Organization 2009-2011
  4. EORTC President 2006-2009, Exec Board 1998-2012, Chairman Melanoma Group(1994-2000)
  5. ASCO: Board of Directors of ASCO (2008-2010; Surgery Chair) and JCO Editorial Board
  6. AACR: Deputy Editor of Clinical Cancer Research 2001-2009
  7. ESMO: Executive Board: 2014-2018
  8. CRUK: Board of Trustees/Strategic Research Committee 2016-2019
  9. DFG: Wissenschaftsrat, Germany: 2017-2020
  10. DKH (Deutsche Krebshilfe) (Since 2007-Now) President International Jury CCC-Program
  11. European Journal of Cancer: Editor-in-Chief since 01-01-2011


Professional awards (selection): Joseph Maisin Chair (Catholic University of Louvain, Belgium (2001); ASCO Statesman Award (2010); Michiel Van Vloten Award of the Dutch Surgical Society (2016); John Wayne Award of Clinical Research of Society Surgical Oncology (2018); Doctorate Honoris Causa (University Essen, Germany) (2018); Honorary Chair KAZIOR (Kazakh Cancer Institute)(2019); Deutsche Krebshilfe Cancer Award (2019); European Academy of Tumor Immunology Award (2023), ESSO Award (2023)

Specialties & Scientific Output: Clinical: immunotherapy, melanoma, sarcoma,drug development. Basic/Translational: tumor immunology, animal models. Scientific Output: >1200 publications; 40 PhD theses @ ErasmusMC: H-index/citations: 127, >81000 citations (Web of Science), HI:128, >82000 (Scopus); HI:137, >97000 (Research Gate); HI:148, >115000 citations (Google Scholar)

Societal Awards: Légion d’Honneur, France (2015)

Organizations

Source: Pubmed

University Medical Center Utrecht

Publications Synthesis

Source: Pubmed

Number : 901

Citations

Citations: 90 830 1st author: 97 Last author: 186 Unique author: 36

Main journals

Eur J Cancer 118
J Clin Oncol 75
Oncoimmunology 54
Eur J Surg Oncol 37
Ann Surg Oncol 35

Best Journals

J Clin Oncol 24
Lancet Oncol 24
N Engl J Med 6

Breakdown by type

Clinical Studies 15

Source: ClinicalTrials

Synthesis

Study Chair: 1

By phase:

Phase 3 10
Phase 2 3
N/A 1
Phase 1/Phase 2 1

By status:

Unknown 5
Active not recruiting 4
Completed 4
Terminated 2

By type:

Interventional 15

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 0
multicentricup10 11

Main Topics

LeadR Networks

Main global connection map

Source: Pubmed Source: ClinicalTrials